MDGL MADRIGAL PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2024 - Underwriting Agreement for Public Offering Madrigal Pharmaceuticals, Inc. entered into an Underwriting Agreement for the sale of common stock and pre-funded warrants in an underwritten public offering, with an estimated net proceeds of approximately $574.0 million.Get access to all SEC 8-K filings of the MADRIGAL PHARMACEUTICALS INC